Search
Now showing items 1-3 of 3
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)
Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients
with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ...
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
(American Academy of Neurology, 2007)
Objective: To measure the frequency and associated risk factors of HIV dementia in an HIV clinic in Kampala, Uganda. Methods: We systematically sampled 78 HIV-seropositive (HIV ) patients from an ambulatory HIV ...
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
(American Academy of Neyurology, 2009)
Background: The frequency of HIV dementia in a recent study of HIV individuals at the Infectious
Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include
stavudine, are the most common ...